BACKGROUND:: This study evaluated the usefulness of MR angiography (MRA)–diffusion-weighted imaging (DWI) mismatch in neuroendovascular therapy over 3 h after onset of acute cerebral infarction. METHODS:: The subjects were 14 cases (age, 73 ± 8.4 years) who had an anterior circulation deficit on DWI/MRA on arrival and underwent neuroendovascular therapy over 3 h after onset. MRA-DWI mismatch (MDM) (+) was defined as ‘major artery lesion (+) and diffusion-weighted image-Alberta Stroke Program Early CT Score (DWI-ASPECTS) ≥6’; MDM (−) was defined as ‘major artery lesion (+) and DWI-ASPECTS <6’. RESULTS:: Reperfusion was achieved in nine of 14 patients (64%) undergoing neuroendovascular therapy. Within the reperfusion group, in the five MDM (+) patients and the four MDM (−) patients, the outcome was a favorable clinical response in the MDM (+) group. The modified Rankin Scale (mRS) scores after 90 days were 0–2 in 3 (60%) and 3–6 in 2 (40%) of the MDM (+) group patients and 0–2 in 0 (0%) and 3–6 in 4 (100%) of the MDM (−) group patients. In the MDM (+) group, a good outcome was achieved. However, the number of cases was small, so this was not a significant difference. Within the non-reperfusion group, in the three MDM (+) patients and the two MDM (−) patients, the mRS scores after 90 days were 0–2 in 1 (33%) and 3–6 in 2 (67%) of the MDM (+) group patients and 0–2 in 0 (0%) and 3–6 in 2 (100%) of the MDM (−) group patients. In both groups, the outcome was poor. CONCLUSIONS:: With neuroendovascular therapy, a good outcome with reperfusion was achieved in the MDM (+) group compared to the MDM (−) group. This suggests that the presence or absence of MDM may be useful in determining prognosis after reperfusion.